Anticancer drugs: To the rescue?
Explore this paper's citation graph
Summary
Tumour biopsies from eight out of nine patients with gefitinib-responsive lung cancer carried these mutations, compared with none from seven nonresponders, and five out of five samples selected that had EGFR mutations were from treatment responders.
- Type
- review
- Published
- 2004-06-01
- Cited by
- 9,828
- References
- 2
- Access
- Open access
- OpenAlex
- https://openalex.org/W2072164644
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27937216
Keywords
Computational biology, Computer science, Medicine, Intensive care medicine, Biology
References
Cited by
- Tumor dormancy and metastasis.
- The study of epidermal growth factor receptor, 99mTechnetium-depreotide, and tumour markers in the management of neuroendocrine tumours
- Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung
- Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead.
- Program to improve cognitive functioning in patients with schizophrenia: reflections.
- Imatinib mesylate for melanoma: will a new target be revealed?
- Predominance of high-grade pathway in breast cancer development of Middle East women
- EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCycler
- Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma
- Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study.
- Predicting drug response and toxicity based on gene polymorphisms.
- Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients
- Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation.
- Tyrosine kinases as targets for cancer therapy.
- Preclinical Evaluation of ZD1839 Alone or in Combination with Oxaliplatin in a Panel of Human Tumor Cell Lines – Implications for Clinical Use
- Erlotinib in the treatment of non-small cell lung cancer
- Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.
- Concordance of pharmacogenetic markers in germline and colorectal tumor DNA.
- Allele-Specific Amplification in Cancer Revealed by SNP Array Analysis
- Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy.
Related papers
- Genentech taps Affimed’s antibodies
- KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria
- Cardiac retransplantation in children.
- Avaliacao hemodinamica sequencial em transplante de coracao
- Thoracoscopic discectomy and fusion in the treatment of spinal deformities
- [Hepatic retransplant and acute Budd Chiari syndrome. Case report].
- Caudal Anaesthesia with Levobupivacaine for Inguinal Hernia Surgery in Children with Severe Congenital Anomaly: A Three-Case Report